Articles tagged with “keytruda-exclusivity”

Merck 2026 Restructuring: Patent Cliff & AI Strategy

Examine Merck's 2026 restructuring and 8% workforce reduction. Understand how the company utilizes AI and M&A to navigate the $300B pharma patent cliff.

55 min read

5/2/2026

merck restructuring pharma patent cliff pharma ai strategy workforce reduction keytruda exclusivity big pharma economics drug development ai